Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs
about
Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in TanzaniaCiprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistanceDetection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts.Extended-spectrum beta-lactamases and clinical outcomes: current data.The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolateResistance to tetracycline and β-lactams and distribution of resistance markers in enteric microorganisms and pseudomonads isolated from the oral cavityEnzymatic analysis of the effect of naturally occurring Leu138Pro mutation identified in SHV β-lactamase on hydrolysis of penicillin and ampicillin.Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamasesBloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomePrevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal.Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic testsCharacterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection methodWhole genome sequencing of extended-spectrum β-lactamase producing Klebsiella pneumoniae isolated from a patient in Lebanon.Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Characterization of multidrug-resistant Escherichia coli isolates from animals presenting at a university veterinary hospital.Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases.CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda.Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011.Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan.AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children.Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.qnrA in CTX-M-producing Escherichia coli isolates from France.The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended-spectrum beta-lactamases.Detection of Extended Spectrum Beta-Lactamases Resistance Genes among Bacteria Isolated from Selected Drinking Water Distribution Channels in Southwestern Nigeria.Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide surveyMultidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain.High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections.Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital.Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.[Prevalence of the TEM, SHV and CTX-M families of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp at the University Hospital of Santa Maria, State of Rio Grande do Sul].Determinants of beta-lactam resistance in meningitis-causing Enterobacteriaceae in Brazil.
P2860
Q24812037-09E3B935-EDC7-4C70-8ABE-6177E5F96EA9Q31125417-48FC8B1F-7DEE-4F5D-9497-250ED9FCA9EAQ33235526-59BE1C8F-1EF3-4864-AE42-56A881344050Q33236875-7881E74B-2536-4D84-9E3B-D4B8085CFC5DQ33634460-D22A995B-14F4-477E-9609-64921260FDF2Q33722024-0C5A5F41-AB31-4F15-8A63-02088119E5E0Q33786967-41B93110-E707-4502-B899-9AC1638BB431Q33811386-AC2A65D8-ED6D-43F9-9106-9E2335E21C6FQ33857230-B2A89522-0E47-4A12-B73F-D7755D4B865EQ33883791-1E5DD1DD-7F26-4E93-866E-5BB12D3BC17EQ34351978-6B264DFA-E3BA-47DE-9D49-EA3D93FB3A11Q34461810-141C2D3A-51F0-4247-BE9B-B59FE1B88E7BQ34749275-4CEF01DB-1A82-4904-8BFE-0644811AB912Q34974437-54AA2997-4B6B-4AEC-A315-F86D63DF9C7AQ35315792-0FB8FAD1-2A30-48CA-B706-C685C5CCF688Q35356144-6B85143D-98A4-44BD-9B4F-D7128D63EB04Q35361994-6EA0FD26-0945-4B8F-8397-33676EE98E7EQ35638321-872C4AA5-8A57-407A-93C6-70E5E7126F34Q35690509-EA744F04-E51F-4476-A396-4026DF637221Q35776482-FCA9F2C6-1061-41FE-A9CD-7A27692E2E57Q37126210-2866D2C2-E5EB-468B-B001-1A759E79863BQ37370433-3A107517-1CF5-40C9-81BE-BDB29C9596A0Q37420296-6F996CCC-480A-4B7C-AA1D-53600D9DF917Q37568397-62C04B36-BB87-4C48-AC22-AB783939026CQ38423644-CDF2CC19-7464-4763-8A32-472170B7FEFFQ39746711-05A1EA9F-F9F8-4024-B026-EDC794F5D452Q40902394-DAA062CF-DAC7-4565-97CB-5C3D08E6AC43Q41002584-D3E65388-D677-47C0-9B54-DEA72615AC86Q41733568-899D2297-9AAD-4248-BA29-B35E00FA7F15Q41807595-73084E83-17FB-4AD9-9405-C6C4811EAC8FQ41821207-8C9086E4-AC79-4C60-9BFA-EB4A18ACEF4DQ41943687-0C3B1983-A70F-4CAD-96F2-386D7D2A8CACQ42054872-DF99F72C-7745-43C3-8C2D-331D12C3BBF8Q42071404-C1F1CCE5-48F6-44A5-8044-DA6AA41DDF76Q45073162-8B7E5B39-BCE9-4E37-8379-76B91906930DQ45850774-DDF5F5CA-DF07-42F5-B06C-8797CE9E28BAQ46653069-1F212893-DA76-44E9-BC0A-7C9B60BA0BE0Q51409908-453E1B15-04F1-4237-9FE3-C6DD478DC6BBQ54394159-0B34608A-6BB9-4AA2-BFFE-1B4DEFA9F124Q54423932-276A529B-8733-4235-A15D-7965F6C1B4D0
P2860
Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Occurrence of extended-spectru ...... and other antimicrobial drugs
@ast
Occurrence of extended-spectru ...... and other antimicrobial drugs
@en
Occurrence of extended-spectru ...... and other antimicrobial drugs
@nl
type
label
Occurrence of extended-spectru ...... and other antimicrobial drugs
@ast
Occurrence of extended-spectru ...... and other antimicrobial drugs
@en
Occurrence of extended-spectru ...... and other antimicrobial drugs
@nl
prefLabel
Occurrence of extended-spectru ...... and other antimicrobial drugs
@ast
Occurrence of extended-spectru ...... and other antimicrobial drugs
@en
Occurrence of extended-spectru ...... and other antimicrobial drugs
@nl
P2093
P2860
P1476
Occurrence of extended-spectru ...... and other antimicrobial drugs
@en
P2093
G Amicosante
Italian ESBL Study Group
P2860
P304
P356
10.1128/AAC.46.1.196-202.2002
P407
P577
2002-01-01T00:00:00Z